Vascular Access Device Clinical Trials

7 recruitingLast updated: June 17, 2026

There are 7 actively recruiting vascular access device clinical trials across 7 countries. Studies span Not Applicable, Phase 3. Top locations include Amsterdam, Netherlands, Boston, Massachusetts, United States, Diyarbakır, Outside of the US, Turkey (Türkiye). Updated daily from ClinicalTrials.gov.


Vascular Access Device Trials at a Glance

7 actively recruiting trials for vascular access device are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Amsterdam, Boston, and Diyarbakır. Lead sponsors running vascular access device studies include Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization, Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital, and Fundacion Miguel Servet.

Browse vascular access device trials by phase

Treatments under study

About Vascular Access Device Clinical Trials

Looking for clinical trials for Vascular Access Device? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Vascular Access Device trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Vascular Access Device clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Serratus Posterior Superior Intercostal Plane Block in Port Catheter Implantation

Postoperative PainVascular Access Device
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital70 enrolled1 locationNCT07579572
Recruiting
Not Applicable

Radiographic External Measurement Technique for TIVAP Placement

Vascular Access DeviceCatherization
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization120 enrolled1 locationNCT07549035
Recruiting
Not Applicable

Comparing Basilic and Cephalic Vein Approaches for Midline Catheter Placement in Children

Vascular Access Device Complications
Seoul National University Hospital96 enrolled1 locationNCT07509359
Recruiting
Not Applicable

Digital Transformation of Continuity of Care for Peripherally Inserted Central Catheters: SpadCare Experience

Central Venous CathetersVascular access devicesPatient Participation+20 more
Fundacion Miguel Servet201 enrolled1 locationNCT06905119
Recruiting

A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascular Access Devices

Vascular Access Device
Teleflex2,500 enrolled3 locationsNCT06604039
Recruiting
Phase 3

Induction Treatment for Initially Unresectable Colorectal Liver Metastases: Combined Hepatic Arterial Infusion Pump Therapy With Systemic Therapy

Liver MetastasesColorectal NeoplasmsFloxuridine+1 more
The Netherlands Cancer Institute306 enrolled1 locationNCT06857773
Recruiting

Preventing adverse events during paediatric cancer treatment: A multi-site hybrid randomised controlled trial of catheter lock solutions (The CLOCK trial)

Central vascular access device (CVAD) related adverse eventsPaediatric Cancer
University of Queensland720 enrolled7 locationsACTRN12622000499785